Abstract
Cauda equina syndrome (CES) associated with dural ectasia is a rare neurologic complication in patients with longstanding ankylosing spondylitis (AS). We report a 68-year-old male with a 30-year history of AS who presented a typical symptom and signs of progressive CES, urinary incontinence and neuropathic pain of the lumbosacral radiculopathy. Computed tomography (CT) and magnetic resonance imaging (MRI) findings showed the unique appearances of dural ectasia, multiple dural diverticula, erosion of posterior element of the lumbar spine, tethering of the conus medullaris and adhesion of the lumbosacral nerve roots to the posterior aspect of the dural ectasia. Considering the progressive worsening of the clinical signs, detethering of the conus medullaris through resection of the filum terminale was performed through a limited laminectomy. However, the urinary incontinence did not improve and there was a partial relief of the neuropathic leg pain only. The possible pathogenetic mechanism of CES-AS and the dural ectasia in this patient with longstanding AS are discussed with a literature review.
Ankylosing spondylitis (AS) is a seronegative spondyloarthropathy primarily affecting the spine and sacroiliac joint. Neurologic sequele of AS is usually accompanied by an atlantoaxial subluxation with spinal cord compression or a pathologic fracture of the rigid spine at cervicothoracic or thoracolumbar junctions even after a minor traumatic event21). The cauda equine syndrome (CES), is a known, but rare neurologic manifestation in patients with long-standing AS (also called CES-AS syndrome) and was first described by Bowie and Glasgow5) and Hauge9) in 1961.
A dural ectasia is a condition in which the spinal dural sac is enlarged usually involving the lumbosacral regions where the cerebrospinal fluid (CSF) pressure is greatest19). The association of CES with dural ectasia or arachnoid cysts in AS was first recognized by Matthews in 196813). Dural ectasia is occasionally seen in patients with Marfan syndrome, neurofibromatosis Type I, Ehlers-Danlos syndrome and longstanding AS12). However, the bony erosion in AS predominantly involves the posterior elements rather than the posterior aspect of vertebral bodies seen in other conditions14).
A 68-year-old male with a 30-year history of AS presented with a 3-month history of aggravation of a progressive urinary incontinence and pain in the left buttock associated with paresthesia of the right buttock which radiated down the back of the leg to the level of the sole. He also presented a three-year history of insidious onset, slowly progressing, urinary incontinence and numbness along the heel and sole of the left foot. On physical examination, the left foot showed a grade IV weakness with an atrophy of the sole. Mild hypesthesia and paresthesia was found in his left posterior calf and sole along the S1 dermatome. The left ankle jerk was diminished. No mechanical allodynia was noticed. The patient had experienced intermittent low back pain in the past, but was not currently asymptomatic regarding this for many years.
On admission, laboratory values were as follows : erythrocyte sedimentation rate 22 (0-15) mm/hr/C-reactive protein 0.23 (range 0.03-0.47) mg/L and negative Anti-Nuclear Ab 2.5. Electromyography and nerve conduction study showed bilateral lumbosacral radiculopathies, clinically equivalent to a cauda equina syndrome, with a more severe involvement of the left side. An urodynamic study showed an evidence of a neurogenic bladder with detrusor hypoactivity and low compliance of the bladder.
Plain X-rays of the lumbosacral spine and subsequent 3D computed tomography (CT) showed the typical 'bamboo spine' of AS with fusion of both sacroiliac joints, squaring of the lumbar vertebral bodies, syndesmophyte formation along the lumbar spine, and also multiple erosions of the roof of an enlarged spinal canal (Fig. 1A, B, C). A CT scan showed the spinal canal enlarged by laminar erosions (Fig. 1D). The magnetic resonance imaging (MRI) demonstrated a widened thecal sac from L4 to S1, with an extensive scalloping of the laminae and a spinous process caused by multiple thecal diverticula (Fig. 2A). Axial T2-weighted images showed a clumping of the nerve roots of the cauda equina on the side of the ecstatic thecal sac suggesting an adhesion of nerve roots to the ararchnoid membrane. The conus medullaris terminated at the level of L1 body, however, the filum terminale seemed to be adherent to the posterior wall of the thecal sac at L1 level (Fig. 2). No abnormal enhancement or mass lesion such as herniated lumbar disc was found.
Considering the chronic progressive course of a CES and the radiologic findings of adherence of filum terminale to the posterior wall of the dural ectasia, dethetering of the filum terminale was performed after getting informed consent from the patient and his relatives.
The dura was opened through a laminectomy of L2 under general anesthesia. The filum terminale was identified under microscopic vision and tested with a low current bipolar stimulation (Fig. 3). After identifying the filum, it was coagulated and sharply divided, and the dura and overlying wound were closed in layers. No adverse effect of the untethering procedure was observed and the postoperative course was uneventful as well. After 6 months of follow up, the urinary incontinence was not improved. The left buttock pain was improved; however, the dysesthetic pain and paresthesia in his left posterior calf and sole were not improved.
AS may be completely asymptomatic and diagnosed when a radiograph is performed for some unrelated reason. It may also re-present after a period of quiescence, or rarely present late with complications. The rate of neurologic complication of AS was reported to be approximately 2.1%2).
CES is one such rare complication. First described by Bowie and Glasgow5), it occurs in a longstanding disease, with usually more than 15 years duration when this disease is inactive and the patient typically has been symptom-free for many years20). Symptoms are usually sensory in nature, affecting lumbosacral roots and frequently include urinary and bowel symptoms that are usually mild, if present. Despite its relative rarity, it is a condition which has been well described, particularly with imaging techniques of CT and MRI1,18).
The exact pathogenesis of dural ectasis and dural diverticua in longstanding AS is still unclear. Under normal conditions, the meninges and the dural sac absorb the CSF and dampen the transmitted CSF pressure. In the longstanding AS, the process of inflammation may extend to the adjacent dura mater from the paraspinal ligament, resulting in an adhesion of the dura mater to the surrounding structures that reduce the compliance and elasticity of the lower dural sac and its ability to dampen the fluctuation in CSF pressure6,9,13). Thus, an inflamed dura may be weakened, further encouraging the development of dural ectasia and bony erosion12).
Several hypothetical mechanisms have been proposed for CES associated with AS (CES-AS syndrome), including small vessel angitis involving the vasa vasorum of the nerve roots, nerve root damage due to dural ectasia with decreased elasticity of the dural sac and increased arterial pulsatile forces transmitted through the CSF, chronic inflammatory process, and previous spinal irradiation due to treatment of AS6,12,13,17). Of the proposed mechanisms, a chronic inflammatory theory of CES-AS syndrome seems to be most plausible considering the chronic progressive clinical course, the MRI findings of tethering of the conus medullaris and the adhesions of the nerve roots to the dorsal aspect of the dural sac and the spinal canal, as well as the development of a CES-AS syndrome between 17 and 53 years (average, 35 years) after the onset of AS4,12,15). However, the exact prevalence of dural ectasia in AS is still unknown yet.
There is no effective medical or surgical treatment for a dural ectasia, presumably an end result of the chronic inflammatory process2,12). According to a meta-analysis on the treatment efficacy of CES-AS syndrome by Ahn et al.2), steroids were not effective in the chronic stage, while non-steroidal anti-inflammatory drugs decreased the back pain but did not improve the neurological deficit, probably owing to a non-active inflammation in the chronic stage of a CES-AS syndrome. Cornec et al.7) reported a case of dramatic clinical improvement in the anal sphincter function and sensation at anus and buttock with infliximab, a monoclonal antibody to tumor necrosis factor α as a major pro-inflammatory cytokine used in the treatment of active AS.
The effectiveness of surgical treatment for CES-AS is still controversial. There were reports6,8,10,11,16) regarding surgical interventions, such as lumboperitoneal shunting or laminectomy that may improve or arrest the progress of pain, sensory, motor, bowel and bladder dysfunction in few patients based on the theory of attributing nerve root damage to excessive pulse pressure in CSF and to nerve root compression from the dural diverticula. However, most reports2,12), including our case, reported only limited or no clinical improvement after surgical treatment. As an explanation for the absence of improvement after surgical treatment, Arslanoglu and Aygun3) proposed that an initial inflammatory process results in an adhesion of the nerve roots of the cauda equina to the dural sac, and the nerve roots are progressively stretched by the enlarging diverticula. Therefore, Liu et al.12) suggested that the effect of medical and surgical treatment may be determined on the timing of the treatment, whether there is active inflammation or irreversible nerve root damage has developed and the MRI finding and CSF findings showing the status of acute or chornic inflammation may provide valuable information in the treatment planning in a patient with CES-AS syndrome.
A CES associated with dural ectasia is a rare, but serious problem in the management of patients with longstanding AS. Although the effectiveness of various medical and surgical treatments is still not established, the prompt identification of this problem with a timely surgical intervention seems to be a reasonable approach in this condition.
References
1. Abelló R, Rovira M, Sanz MP, Gili J, Capdevila A, Escalada J, et al. MRI and CT of ankylosing spondylitis with vertebral scalloping. Neuroradiology. 1988; 30:272–275. PMID: 3405419.
2. Ahn NU, Ahn UM, Nallamshetty L, Springer BD, Buchowski JM, Funches L, et al. Cauda equina syndrome in ankylosing spondylitis (the CES-AS syndrome) : meta-analysis of outcomes after medical and surgical treatments. J Spinal Disord. 2001; 14:427–433. PMID: 11586143.
3. Arslanoglu A, Aygun N. Magnetic resonance imaging of cauda equina syndrome in long-standing ankylosing spondylitis. Australas Radiol. 2007; 51:375–377. PMID: 17635477.
4. Bartleson JD, Cohen MD, Harrington TM, Goldstein NP, Ginsburg WW. Cauda equina syndrome secondary to long-standing ankylosing spondylitis. Ann Neurol. 1983; 14:662–669. PMID: 6651250.
5. Bowie EA, Glasgow GL. Cauda equina lesions associated with ankylosing spondylitis. Br Med J. 1961; 2:24–27. PMID: 20789178.
6. Confavreux C, Larbre JP, Lejeune E, Sindou M, Aimard G. Cerebrospinal fluid dynamics in the tardive cauda equina syndrome of ankylosing spondylitis. Ann Neurol. 1991; 29:221–223. PMID: 2012391.
7. Cornec D, Devauchelle Pensec V, Joulin SJ, Saraux A. Dramatic efficacy of infliximab in cauda equina syndrome complicating ankylosing spondylitis. Arthritis Rheum. 2009; 60:1657–1660. PMID: 19479855.
8. Dinichert A, Cornelius JF, Lot G. Lumboperitoneal shunt for treatment of dural ectasia in ankylosing spondylitis. J Clin Neurosci. 2008; 15:1179–1182. PMID: 18710808.
9. Hauge T. Chronic rheumatoid polyarthritis and spondyl-arthritis associated with neurological symptoms and signs occasionally simulating an intraspinal expansive process. Acta Chir Scand. 1961; 120:395–401. PMID: 13712291.
10. Lan HH, Chen DY, Chen CC, Lan JL, Hsieh CW. Combination of transverse myelitis and arachnoiditis in cauda equina syndrome of long-standing ankylosing spondylitis : MRI features and its role in clinical management. Clin Rheumatol. 2007; 26:1963–1967. PMID: 17332972.
11. Larner AJ, Pall HS, Hockley AD. Arrested progression of the cauda equina syndrome of ankylosing spondylitis after lumboperitoneal shunting. J Neurol Neurosurg Psychiatry. 1996; 61:115–116. PMID: 8676141.
12. Liu CC, Lin YC, Lo CP, Chang TP. Cauda equina syndrome and dural ectasia : rare manifestations in chronic ankylosing spondylitis. Br J Radiol. 2011; 84:e123–e125. PMID: 21606066.
13. Matthews WB. The neurological complications of ankylosing spondylitis. J Neurol Sci. 1968; 6:561–573. PMID: 4303835.
14. Nallamshetty L, Ahn NU, Ahn UM, Nallamshetty HS, Rose PS, Buchowski JM, et al. Dural ectasia and back pain : review of the literature and case report. J Spinal Disord Tech. 2002; 15:326–329. PMID: 12177551.
15. Rubenstein DJ, Alvarez O, Ghelman B, Marchisello P. Cauda equina syndrome complicating ankylosing spondylitis : MR features. J Comput Assist Tomogr. 1989; 13:511–513. PMID: 2723187.
16. Shaw PJ, Allcutt DA, Bates D, Crawford PJ. Cauda equina syndrome associated with multiple lumbar arachnoid cysts in ankylosing spondylitis : improvement following surgical therapy. J Neurol Neurosurg Psychiatry. 1990; 53:1076–1079. PMID: 2292702.
17. Soeur M, Monseu G, Baleriaux-Waha D, Duchateau M, Williame E, Pa-steels JL. Cauda equina syndrome in ankylosing spondylitis. Anatomical, diagnostic, and therapeutic considerations. Acta Neurochir (Wien). 1981; 55:303–315. PMID: 7234535.
18. Sparling MJ, Bartleson JD, McLeod RA, Cohen MD, Ginsburg WW. Magnetic resonance imaging of arachnoid diverticula associated with cauda equina syndrome in ankylosing spondylitis. J Rheumatol. 1989; 16:1335–1337. PMID: 2509695.
19. Tallroth K, Malmivaara A, Laitinen ML, Savolainen A, Harilainen A. Lum-bar spine in Marfan syndrome. Skeletal Radiol. 1995; 24:337–340. PMID: 7570153.
20. Tyrrell PN, Davies AM, Evans N. Neurological disturbances in ankylosing spondylitis. Ann Rheum Dis. 1994; 53:714–717. PMID: 7826132.
21. Westerveld LA, Verlaan JJ, Oner FC. Spinal fractures in patients with ankylosing spinal disorders : a systematic review of the literature on treatment, neurological status and complications. Eur Spine J. 2009; 18:145–156. PMID: 18791749.